Latest filing published 02 Jul 2019 for Merrimack Pharmaceuticals INC, €51k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
JFL Capital Management, LLC: trading record in brief
All filings by JFL Capital Management, LLC on record concern Merrimack Pharmaceuticals Inc. Over a trading history stretching from 5 April 2019 to 2 July 2019, the count stands at 9 filings.
Purchases make up the whole of the open-market record (9 purchases, €458k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
A typical purchase (the median) is worth €36k. 3 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The record was last updated on 2 July 2019 with an open-market purchase (€51k) in Merrimack Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to JFL Capital Management, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,662 shares@ US$5.94511.0% of flowCommon StockSEC:0000921895-19-001955:0Canonical exit: 26 Sept 2019 (T+90)
- 13,902 shares@ US$5.94515.9% of flowCommon StockSEC:0000921895-19-001955:1Canonical exit: 26 Sept 2019 (T+90)
- 3,934 shares@ US$6.00294.6% of flowCommon StockSEC:0000921895-19-001955:2Canonical exit: 29 Sept 2019 (T+90)
- 5,659 shares@ US$6.00296.6% of flowCommon StockSEC:0000921895-19-001955:3Canonical exit: 29 Sept 2019 (T+90)
- 7,024 shares@ US$5.8487.9% of flowCommon StockSEC:0000921895-19-001955:4Canonical exit: 30 Sept 2019 (T+90)
- 10,107 shares@ US$5.84811.4% of flowCommon StockSEC:0000921895-19-001955:5Canonical exit: 30 Sept 2019 (T+90)
- 26,288 shares@ US$5.95230.4% of flowCommon StockSEC:0000921895-19-001055:0Canonical exit: 4 Jul 2019 (T+90)
- 6,484 shares@ US$5.72647.2% of flowCommon StockSEC:0000921895-19-001055:1Canonical exit: 7 Jul 2019 (T+90)
- 4,506 shares@ US$5.72645.0% of flowCommon StockSEC:0000921895-19-001055:2Canonical exit: 7 Jul 2019 (T+90)
9 of 9 declarations
